35 related articles for article (PubMed ID: 8384741)
1. Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.
Lund AH; Schmidt J; Luz A; Sørensen AB; Duch M; Pedersen FS
J Virol; 1999 Jul; 73(7):6117-22. PubMed ID: 10364369
[TBL] [Abstract][Full Text] [Related]
2. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus.
Glud SZ; Sørensen AB; Andrulis M; Wang B; Kondo E; Jessen R; Krenacs L; Stelkovics E; Wabl M; Serfling E; Palmetshofer A; Pedersen FS
Blood; 2005 Nov; 106(10):3546-52. PubMed ID: 16051745
[TBL] [Abstract][Full Text] [Related]
3. Characterization of recombinant nonecotropic murine leukemia viruses from the wild mouse species Mus spretus.
Jung YT; Wu T; Kozak CA
J Virol; 2003 Dec; 77(23):12773-81. PubMed ID: 14610199
[TBL] [Abstract][Full Text] [Related]
4. Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus.
Rulli K; Lenz J; Levy LS
J Virol; 2002 Mar; 76(5):2363-74. PubMed ID: 11836414
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution and timing of appearance of polytropic envelope recombinants during infection with SL3-3 murine leukemia virus or its weakly pathogenic SL3DeltaMyb5 mutant.
Rulli K; Lobelle-Rich PA; Trubetskoy A; Lenz J; Levy LS
J Virol; 2001 Jan; 75(1):522-6. PubMed ID: 11119621
[TBL] [Abstract][Full Text] [Related]
6. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
7. Murine leukemia viruses with recombinant env genes: a discussion of their role in leukemogenesis.
Famulari NG
Curr Top Microbiol Immunol; 1983; 103():75-108. PubMed ID: 6303710
[No Abstract] [Full Text] [Related]
8. Detection of murine leukemia viruses--in vitro infectivity tests.
Hartley JW
Dev Biol Stand; 1992; 76():179-86. PubMed ID: 1335932
[TBL] [Abstract][Full Text] [Related]
9. Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus.
Thomas CY; Nuckols JD; Murphy C; Innes D
Virology; 1993 Apr; 193(2):1013-7. PubMed ID: 8384741
[TBL] [Abstract][Full Text] [Related]
10. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
[TBL] [Abstract][Full Text] [Related]
11. Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice.
Tumas KM; Poszgay JM; Avidan N; Ksiazek SJ; Overmoyer B; Blank KJ; Prystowsky MB
Virology; 1993 Feb; 192(2):587-95. PubMed ID: 7678475
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.
Lawrenz-Smith SC; Massey AC; Innes DJ; Thomas CY
J Virol; 1994 Aug; 68(8):5174-83. PubMed ID: 8035516
[TBL] [Abstract][Full Text] [Related]
13. Precise identification of endogenous proviruses of NFS/N mice participating in recombination with moloney ecotropic murine leukemia virus (MuLV) to generate polytropic MuLVs.
Alamgir AS; Owens N; Lavignon M; Malik F; Evans LH
J Virol; 2005 Apr; 79(8):4664-71. PubMed ID: 15795252
[TBL] [Abstract][Full Text] [Related]
14. The mouse H-2A region influences the envelope gene structure of tumor-associated murine leukemia viruses.
Nuckols JD; Thomas CY
J Virol; 1998 May; 72(5):3973-9. PubMed ID: 9557684
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
